Patents Assigned to Alanex Corporation
  • Patent number: 5861398
    Abstract: Benzo(e)perimidine-4-carboxamide derivatives of general structural formula I ##STR1## (where R.sub.a, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are as defined in the specification) have activity for receptors of corticotropin releasing factor (CRF). The compounds are useful in treating stress-related diseases, cardiovascular, neurological and psychiatric disorders including anxiety, depression, eating disorders, anorexia nervosa, superanuclear palsy, irritable bowel syndrome, gastrointestinal diseases, immune suppression, inflammatory disorders, drug and alcohol withdrawal symptoms, drug addiction, Alzheimer's disease or fertility disorders.
    Type: Grant
    Filed: August 26, 1996
    Date of Patent: January 19, 1999
    Assignee: Alanex Corporation
    Inventors: Aleksandr K. Rabinovich, Dale S. Dhanoa, David R. Luthin, Richard A. Bychowski, Dilip R. Bhumralkar
  • Patent number: 5811665
    Abstract: A system for preparative sorption driven chromatographic separation of organic compounds comprising a chromatographic element having a focusing zone in a porous tip with a vertex having a first diameter for receiving sample and solvent and a base having a wider second diameter, and an elongated resolving zone of at least the second diameter is disclosed. The system may further include a porous solvent transfer block for transferring solvent from a source to the tip. A method of chromatographically isolating an organic compound using the system is disclosed.
    Type: Grant
    Filed: September 11, 1996
    Date of Patent: September 22, 1998
    Assignee: Alanex Corporation
    Inventors: Vlad E. Gregor, Scott Schreckengaust